[14C]ZIPALERTINIB clinical trials

A PHASE 1 STUDY TO ASSESS THE MASS BALANCE, PHARMACOKINETICS, AND METABOLISM OF ORAL [14C]-ZIPALERTINIB IN HEALTHY ADULT MALE SUBJECTS

This early-stage study in healthy adult men looks at how a new cancer drug called zipalertinib is handled by the body. We want to understand how it's absorbed, changed, and leaves the body, and check for any side effects.